Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs and Conditioned Medium for Keloid Regression
NCT04326959Phase 2Unknown
- Sponsor
- Prodia Stem Cell Indonesia
- Start
- Sep 2020
- Primary completion
- Sep 2020
- Modality
- Stem Cell Therapies
01
Overview
Phase 2 trial of umbilical cord-mesenchymal stem cells in keloid (3 arms), sponsored by Prodia Stem Cell Indonesia. Primary endpoints: Alfa SMA-1 expression at 3 months and Collagen type 1 expression at 3 months. Status: unknown.
02
Drugs
umbilical cord-mesenchymal stem cells
03
Conditions
keloid
Beyond the preview
Go deeper on NCT04326959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04326959.